Brief: Enorama Pharma Reports Q4 Net Sales Of SEK 1.75 Million
18/03/2026 08:23
March 18 (Reuters) - Enorama Pharma AB ERMA.ST: Q4 2025 NET SALES AMOUNT TO 1,750 KSEK Q4 2025 OPERATING RESULT AMOUNTS TO -18,472 KSEK Source text: ID:nWkr6pcFG1 Further company coverage: ERMA.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO